News | RIVM

Potential effects of the reuse of building material on soil quality

In a circular economy, building materials have a longer life cycle and are reused in innovative ways. Reusing building materials is sustainable, but can also be risky as building materials may contain contaminants such as heavy metals.

Nitrate leaching on derogation farms in sandy regions continues to rise

Nitrate leaching on ‘derogation farms’ has risen in recent years, most likely due to the drought experienced throughout the Netherlands in 2018 and regionally in both 2019 and 2020.

Pressure drainage can be a cost-effective technology to reduce CO2 emissions in peatland areas

Pressure drainage can in some cases help to reduce CO2 emissions in peatland areas. This intervention is very expensive and only cost-effective when it sufficiently reduces CO2 emissions.

New test for Lyme disease is not reliable

To determine whether someone has Lyme disease, doctors in the Netherlands often use antibody tests. For some time now, so-called cellular tests have been available on the market.

Verschillende commerciële laboratoria gebruiken zogeheten cellulaire testen voor Lyme. Helaas zijn niet betrouwbaar.

Ten years of Tick Radar 80,000 tick bite reports; chances of being bitten highest in Drenthe

After recording 80,000 tick bites in 10 years via Tekenradar.nl, we now know that you are most likely to be bitten by a tick in Drenthe. Quickly removing the tick halves the chance of contracting Lyme disease.

Call for global action plan to save our oceans

Scientists involved in the Seas Oceans and Public Health In Europe (SOPHIE) Project have proposed the first steps towards a united global plan to save our oceans, for the sake of human health.

Andrzej-kryszpiniuk

Spread of tick-borne encephalitis virus in the Netherlands

Every year about 1.5 million ticks bite someone in the Netherlands, especially between March and October. Most people will not get sick of that.

New test has no added value in Lyme disease of the central nervous system

Active Lyme disease of the central nervous system cannot be detected with an ELISpot test.

Lyme disease costs EUR 20 million annually

The societal costs of Lyme disease have been determined for the Netherlands for the first time. The disease appears to cost nearly EUR 20 million each year.

Lab tests alone not conclusive for diagnosis of Lyme disease

Lyme disease can cause a variety of complaints in patients. Laboratory tests for the disease can support medical practitioners in making a diagnosis but are not necessarily conclusive.